A study of the degree of inflammatory response of atherosclerotic plaque in the coronary artery in patients with impaired metabolism of homocysteine and vitamin D

Authors

DOI:

https://doi.org/10.14739/2310-1237.2020.3.221824

Keywords:

coronary heart disease, homocysteine, vitamin D, hyperhomocysteinemia, atherosclerotic plaque, endothelial dysfunction

Abstract

 

Increased homocysteine (HC) levels and vitamin D deficiency play an important role in the progression of cardiovascular disease (CVD). However, to date, in medical publications, the issues of the influence of hyperhomocysteinemia (HHC) and vitamin D deficiency on the degree of the inflammatory response of atherosclerotic plaque (AsP) are insufficiently covered, which requires a detailed study of this problem. There is an opinion that inflammation contributes to the pathogenesis of CVD, therefore the identification of inflammation markers can improve the assessment of the risk of cardiovascular diseases.

The aim of the study was to assess the morphological picture of inflammatory lesions of the atherosclerotic plaque depending on the degree of hyperhomocysteinemia and levels of vitamin D deficiency in patients with coronary artery disease.

Materials and methods. The study analyzed data from 26 patients who, in addition to determining the level of homocysteine and vitamin D, underwent morphological studies of atherosclerotic plaque from the lumen of the coronary arteries. Samples were obtained during coronary artery bypass grafting. Depending on the level of HC and vitamin D, the patients were divided into 3 groups: the first group – patients with normal levels of homocysteine (up to 10 µmol/L) and vitamin D (more than 30 µmol/L); the second group – patients with hyperhomocysteinemia (10.38–40.08 μmol/l) and a sufficient level of vitamin D (more than 30 ng/ml); The third group – patients with hyperhomocysteinemia (more than 10.38 μmol/l) and vitamin D deficiency (less than 30 ng/ml).

Results. Evaluating the morphology of AsP, we were interested in the presence of lymphocytes and segmented neutrophils, indicating an inflammatory process in the atherosclerotic plaque. In our work, a positive correlation was established between the concentration of HC (γ = 0.92) and the degree of the inflammatory response of ASB. A negative correlation was also found between the level of vitamin D (γ = -0.81) and the degree of ASP inflammation. The overwhelming number of patients, both 2 and 3 groups of the study, had exacerbations of the inflammatory process of ASB, which was confirmed by the presence of segmented neutrophils (7–10 segments in 2 mm2 plaques), corresponding to the 3rd degree of the inflammatory reaction.

Conclusions. Most CHD patients have high homocysteine levels and vitamin D deficiency. Hyperhomocysteinemia and hypovitaminosis D affect the quantitative and qualitative complications of atherosclerotic plaque. Patients with severe hyperhomocysteinemia and vitamin D deficiency had a more pronounced inflammatory response of atherosclerotic plaque.

References

Nykonenko, O. S., Chmul, K. O., Nykonenko, A. O., Osaulenko, V. V., Efimenko, & N. F (2018). Prognostic value of homocysteine and vitamin D for patients with ischemic heart disease and multifocal atherosclerosis. Zaporozhye medical journal, 20(1), 31-35. https://doi.org/10.14739/2310-1210.2018.1.121880

Nikonenko, A. S., Chmul, K. O., Nikonenko, A. A., Molodan, O. V., & Osaulenko, V. V. (2018). Skorochuvalna funktsiia miokarda livoho shlunochka pry porushenni metabolizmu homotsysteinu u khvorykh na ishemichnu khvorobu sertsia [The contractive function of the myocardium of the LV in the disturbance of homocysteine metabolism in IHD patients]. Visnyk sertsevo-sudynnoi khirurhii, (3), 17-23. [in Ukrainian].

Vaziri N. D. (2008). Causal link between oxidative stress, inflammation, and hypertension. Iranian journal of kidney diseases, 2(1), 1-10.

Mikhailova, K. V. (2008). Vliyanie gipergomotsisteinemii na narusheniya vnutrisosudistogo svertyvaniya krovi i klinicheskoe techenie infarkta miokarda (Dis. kand. med. nauk) [Influence of hyperhomocysteinemia on intravascular coagulation disorders and clinical course of myocardial infarction (PhD Dissertation)]. Moscow: Russian State Medical University. [in Russian].

Soboleva E. V. (2008). Novye vozmozhnosti v terapii ishemicheskoi bolezni serdtsa. Spravochnik poliklinicheskogo vracha [New possibilities in the treatment of coronary heart disease]. Spravochnik poliklinicheskogo vracha, (8), 13-15. [in Russian].

McQuillan, B. M., Beilby, J. P., Nidorf, M., Thompson, P. L., & Hung, J. (1999). Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation, 99(18), 2383-2388. https://doi.org/10.1161/01.cir.99.18.2383

Naumov, A. V., Danilchyk, I. V., & Sarana, Yu. V. (2016). Tri puti remetilirovaniya gomotsisteina [Three ways of homocysteine remthylation]. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta, (2), 27-32. [in Russian].

Skvortsov, Yu. I., & Korolkova, A. S. (2011). Gomotsistein kak faktor riska razvitiya IBS (obzor) [Homocysteine as a risk factor of ischemic heart disease development (review)]. Saratovskii nauchno-meditsinskii zhurnal, 7(3), 619-624. [in Russian].

Smirnova, O. A. (2008). Prognosticheskoe znachenie gipergomotsisteinemii u bol'nykh s razlichnymi formami ishemicheskoi bolezni serdtsa (Dis. kand. med. nauk) [Prognostic value of hyperhomocysteinemia in patients with various forms of ischemic heart disease (PhD Dissertation)]. Russian Research Institute of Hematology and Transfusiology. [in Russian].

Wang, N., Chen, C., Zhao, L., Chen, Y., Han, B., Xia, F., Cheng, J., Li, Q., & Lu, Y. (2018). Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis. EBioMedicine, 28, 187-193. https://doi.org/10.1016/j.ebiom.2017.12.027

Moretti, R., Caruso, P., Dal Ben, M., Conti, C., Gazzin, S., & Tiribelli, C. (2017). Vitamin D, Homocysteine, and Folate in Subcortical Vascular Dementia and Alzheimer Dementia. Frontiers in aging neuroscience, 9, 169. https://doi.org/10.3389/fnagi.2017.00169

Kulikov, V. P., Tchernikova, I. V., & Kostutchenco, G. I. (2006). Osobennosti ateroskleroticheskogo porazheniya sonnykh arterii v zavisimosti ot kontsentratsii v krovi gomotsisteina i C-reaktivnogo belka [Associacion between carotid artery atherosclerotic lesions and plasma homocysteine concentrations, рlasma C-reactive рrotein сoncentrations]. Byulleten Sibirskogo otdeleniya Rossiiskoi akademii meditsinskikh nauk, (2), 93-99. [in Russian].

McQuillan, B. M., Beilby, J. P., Nidorf, M., Thompson, P. L., & Hung, J. (1999). Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation, 99(18), 2383-2388. https://doi.org/10.1161/01.cir.99.18.2383

Milevskaya, I. V. (2008). Klinicheskoe znachenie gomotsisteina u bol'nykh arterial'noi gipertoniei (Dis. kand. med. nauk) [The clinical significance of homocysteine in patients with arterial hypertension (PhD Dissertation)]. Samara State Medical University. [in Russian].

Alani, H., Tamimi, A., & Tamimi, N. (2014). Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World journal of nephrology, 3(4), 156-168. https://doi.org/10.5527/wjn.v3.i4.156

Sander, D., Winbeck, K., Klingelhöfer, J., Etgen, T., & Conrad, B. (2004). Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity. Circulation, 109(8), 1010-1015. https://doi.org/10.1161/01.CIR.0000117232.30832.EC

Downloads

How to Cite

1.
Nykonenko OS, Nykonenko AO, Chmul KO, Osaulenko VV. A study of the degree of inflammatory response of atherosclerotic plaque in the coronary artery in patients with impaired metabolism of homocysteine and vitamin D. Pathologia [Internet]. 2020Dec.29 [cited 2024Apr.19];(3). Available from: http://pat.zsmu.edu.ua/article/view/221824

Issue

No. 3 (2020)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Лицензия Creative Commons
    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).